Compare $MTNB vs $REVB | Chartloom

Compare

$MTNB vs $REVB

Matinas BioPharma Holdings Inc · Revelation Biosciences Inc

MTNB

Matinas BioPharma Holdings Inc

REVB

Revelation Biosciences Inc

Compare $MTNB vs $REVB

Comparing Matinas BioPharma Holdings Inc and Revelation Biosciences Inc

MTNBMatinas BioPharma Holdings Inc

REVBRevelation Biosciences Inc

MTNBMatinas BioPharma Holdings Inc

Market cap

$39M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-89.8%

FCF yield

-16.3%

REVBRevelation Biosciences Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.6%

52W performance

-87.1%

FCF yield

-317.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MTNB

REVB

Detailed metrics comparison

MTNB

Matinas BioPharma Holdings Inc

REVB

Revelation Biosciences Inc

Market Cap

MTNB$39M

REVB$3M

Enterprise Value

MTNB$39M

REVB$-9M

Price

MTNB$2.87

REVB$0.76

P/E Ratio

MTNBN/A

REVBN/A

P/S Ratio

MTNB0.60x

REVB0.00x

EV/Sales

MTNB0.43x

REVB0.00x

EV/EBITDA

MTNB0.00x

REVB0.00x

P/B Ratio

MTNB1.44x

REVB0.30x

P/FCF Ratio

MTNBN/A

REVBN/A

EV/FCF

MTNB-6.00x

REVB0.90x

PEG Ratio

MTNBN/A

REVBN/A

Forward P/E (NTM)

MTNBN/A

REVBN/A

Forward P/S (NTM)

MTNBN/A

REVBN/A

Revenue (TTM)

MTNB$0

REVB$0

Revenue Growth (YoY)

MTNBN/A

REVBN/A

Forward Rev Growth

MTNB0.0%

REVB115.3%

Gross Margin (TTM)

MTNB0.0%

REVB0.0%

Operating Margin (TTM)

MTNB0.0%

REVB0.0%

EBITDA Margin (TTM)

MTNB0.0%

REVB0.0%

Net Margin (TTM)

MTNB0.0%

REVB0.0%

FCF Margin (TTM)

MTNBN/A

REVBN/A

Net Income (TTM)

MTNB$-3M

REVB$-19M

FCF (TTM)

MTNB$-6M

REVB$-9M

EPS (TTM)

MTNB$0.00

REVB-$5.01

ROE (TTM)

MTNB-13745.0%

REVB-10020.0%

ROA (TTM)

MTNB-9202.0%

REVB-8273.0%

ROIC (TTM)

MTNB-13717.0%

REVB-10020.0%

Cash

MTNB$761K

REVB$11M

Debt

MTNB$6K

REVB$0

Net Cash/Debt

MTNB$755K

REVB$11M

Current Ratio (TTM)

MTNB0.85x

REVB6.21x

Quick Ratio (TTM)

MTNB0.60x

REVB6.11x

Debt/Equity (TTM)

MTNB0.00x

REVB0.00x

Debt/Assets (TTM)

MTNB0.0%

REVB0.0%

Interest Coverage (TTM)

MTNBN/A

REVBN/A

Net Debt/EBITDA (TTM)

MTNB0.00x

REVB0.00x

Beta

MTNB2.20

REVB-0.14

52W Performance

MTNB-89.8%

REVB-87.1%

YTD Performance

MTNB-69.1%

REVB-76.6%

% from 52W High

MTNB-90.1%

REVB-87.8%

% from 52W Low

MTNB27.1%

REVB1.3%

Asset Turnover (TTM)

MTNB0.09x

REVB0.00x

FCF Yield (TTM)

MTNB-16.3%

REVB-317.7%

Earnings Yield (TTM)

MTNB-8.8%

REVB-646.3%

Dividend Yield (TTM)

MTNBN/A

REVBN/A

Rule of 40

MTNB0.0

REVB0.0

EV/GP/RG

MTNBN/A

REVBN/A

Ticker research

View MTNB research View REVB research

Metric	MTNB Matinas BioPharma Holdings Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$39M	$3M
Enterprise Value	$39M	$-9M
Price	$2.87	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.60x	0.00x
EV/Sales	0.43x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.44x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.00x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	115.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-19M
FCF (TTM)	$-6M	$-9M
EPS (TTM)	$0.00	-$5.01
ROE (TTM)	-13745.0%	-10020.0%
ROA (TTM)	-9202.0%	-8273.0%
ROIC (TTM)	-13717.0%	-10020.0%
Financial Health
Cash	$761K	$11M
Debt	$6K	$0
Net Cash/Debt	$755K	$11M
Current Ratio (TTM)	0.85x	6.21x
Quick Ratio (TTM)	0.60x	6.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.20	-0.14
52W Performance	-89.8%	-87.1%
YTD Performance	-69.1%	-76.6%
% from 52W High	-90.1%	-87.8%
% from 52W Low	27.1%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.00x
FCF Yield (TTM)	-16.3%	-317.7%
Earnings Yield (TTM)	-8.8%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MTNB research	View REVB research

Valuation

P/S Ratio

REVB

0.00x

MTNB

0.60x

EV/FCF

MTNB

-6.00x

REVB

0.90x

Growth & revenue

Forward Revenue Growth

REVB

115.3%

MTNB

0.0%

Profitability & performance

Gross Margin

MTNB

0.0%

REVB

0.0%

ROE

REVB

-10020.0%

MTNB

-13745.0%

FCF Yield %

MTNB

-16.3%

REVB

-317.7%

52-Week Performance

REVB

-87.1%

MTNB

-89.8%

Detailed metrics comparison

MTNB

Matinas BioPharma Holdings Inc

REVB

Revelation Biosciences Inc

Market Cap

MTNB$39M

REVB$3M

Enterprise Value

MTNB$39M

REVB$-9M

Price

MTNB$2.87

REVB$0.76

P/E Ratio

MTNBN/A

REVBN/A

P/S Ratio

MTNB0.60x

REVB0.00x

EV/Sales

MTNB0.43x

REVB0.00x

EV/EBITDA

MTNB0.00x

REVB0.00x

P/B Ratio

MTNB1.44x

REVB0.30x

P/FCF Ratio

MTNBN/A

REVBN/A

EV/FCF

MTNB-6.00x

REVB0.90x

PEG Ratio

MTNBN/A

REVBN/A

Forward P/E (NTM)

MTNBN/A

REVBN/A

Forward P/S (NTM)

MTNBN/A

REVBN/A

Revenue (TTM)

MTNB$0

REVB$0

Revenue Growth (YoY)

MTNBN/A

REVBN/A

Forward Rev Growth

MTNB0.0%

REVB115.3%

Gross Margin (TTM)

MTNB0.0%

REVB0.0%

Operating Margin (TTM)

MTNB0.0%

REVB0.0%

EBITDA Margin (TTM)

MTNB0.0%

REVB0.0%

Net Margin (TTM)

MTNB0.0%

REVB0.0%

FCF Margin (TTM)

MTNBN/A

REVBN/A

Net Income (TTM)

MTNB$-3M

REVB$-19M

FCF (TTM)

MTNB$-6M

REVB$-9M

EPS (TTM)

MTNB$0.00

REVB-$5.01

ROE (TTM)

MTNB-13745.0%

REVB-10020.0%

ROA (TTM)

MTNB-9202.0%

REVB-8273.0%

ROIC (TTM)

MTNB-13717.0%

REVB-10020.0%

Cash

MTNB$761K

REVB$11M

Debt

MTNB$6K

REVB$0

Net Cash/Debt

MTNB$755K

REVB$11M

Current Ratio (TTM)

MTNB0.85x

REVB6.21x

Quick Ratio (TTM)

MTNB0.60x

REVB6.11x

Debt/Equity (TTM)

MTNB0.00x

REVB0.00x

Debt/Assets (TTM)

MTNB0.0%

REVB0.0%

Interest Coverage (TTM)

MTNBN/A

REVBN/A

Net Debt/EBITDA (TTM)

MTNB0.00x

REVB0.00x

Beta

MTNB2.20

REVB-0.14

52W Performance

MTNB-89.8%

REVB-87.1%

YTD Performance

MTNB-69.1%

REVB-76.6%

% from 52W High

MTNB-90.1%

REVB-87.8%

% from 52W Low

MTNB27.1%

REVB1.3%

Asset Turnover (TTM)

MTNB0.09x

REVB0.00x

FCF Yield (TTM)

MTNB-16.3%

REVB-317.7%

Earnings Yield (TTM)

MTNB-8.8%

REVB-646.3%

Dividend Yield (TTM)

MTNBN/A

REVBN/A

Rule of 40

MTNB0.0

REVB0.0

EV/GP/RG

MTNBN/A

REVBN/A

Ticker research

View MTNB research View REVB research

Metric	MTNB Matinas BioPharma Holdings Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$39M	$3M
Enterprise Value	$39M	$-9M
Price	$2.87	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.60x	0.00x
EV/Sales	0.43x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.44x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.00x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	115.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-19M
FCF (TTM)	$-6M	$-9M
EPS (TTM)	$0.00	-$5.01
ROE (TTM)	-13745.0%	-10020.0%
ROA (TTM)	-9202.0%	-8273.0%
ROIC (TTM)	-13717.0%	-10020.0%
Financial Health
Cash	$761K	$11M
Debt	$6K	$0
Net Cash/Debt	$755K	$11M
Current Ratio (TTM)	0.85x	6.21x
Quick Ratio (TTM)	0.60x	6.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.20	-0.14
52W Performance	-89.8%	-87.1%
YTD Performance	-69.1%	-76.6%
% from 52W High	-90.1%	-87.8%
% from 52W Low	27.1%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.00x
FCF Yield (TTM)	-16.3%	-317.7%
Earnings Yield (TTM)	-8.8%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MTNB research	View REVB research